Dauricine can inhibit the activity of proliferation of urinary tract tumor cells  by Wang, Jun et al.
973
Document heading
Dauricine can inhibit the activity of proliferation of urinary tract tumor cells
 Jun Wang, Yuan Li, Xiong-Bing Zu, Min-Feng Chen, Lin Qi*
Department of Urology, Xiangya Hospital, Central South University, Changsha Hunan Province, China
Asian Pacific Journal of Tropical Medicine (2012)973-976
Asian Pacific Journal of Tropical Medicine
journal homepage:www.elsevier.com/locate/apjtm
    *Corresponding author: Lin Qi. Department of Urology, Xiangya Hospital, Central 
South University, Xiangya Road No.87, Changsha 410008, Hunan Province, China.
     Tel: 15116332275
     E-mail: wangjun2538@126.com
1. Introduction
 
  Phenolicalkaloids of Menispermum dauricum (PAMD) is 
mixture of dry root extracts from menispermaceae medicinal 
plants north bean root (Menispermum dauricum)[1], studies 
have found that the main component are dauricine (Dau) 
and daurisoline (Ds). From north bean root, a variety of 
alkaloids component can be separated[2], pharmacological 
experiments, Dau can protect the rats nerve when short 
artery occlusion occured[3], can inhibit the effect of 
potassium ion outflow[4], it also participate in calcium ion 
disturbance[5], induce breast cancer tumor cell apoptosis. 
Dau also inhibit nuclear factor signal path, inhibit colon 
cancer cell proliferation[6], also can produce influence on 
injury neurons apoptosis and related protein expressionrats 
after ischemia-reperfusion[7], PAMD has an resisting 
effect on ischemic arrhythmias, hypertensive, platelet 
adhesion and accumulation, thrombosis, and also plays a 
role of immune regulation, inducing tumor cell apoptosis, 
reversing multi-drug resistant effect. In recent years, to 
Dau antineoplastic, related research has also been reported, 
but rare reports about the urinary system tumor, with effects 
of Dau.
   In the study, the chemical method was applied to extract 
and assay composition of monomer from north bean root 
extract, using MTT staining method to observe the in vitro 
anti-tumor effect of Dau and Ds against tumor cells in 
urinary system, in order to further mining Dau in cancer 
development and application.
2. Materials and methods
2.1.  Tumor cell lines
   Bladder cancer EJ cell line was provided by The Second 
Affiliated Hospital of Zhengzhou University. People 
prostate cancer PC-3M cell line was provided by biological 
laboratory of Zhengzhou University. The original generation 
cells were taken from resection specimen after urology 
surgery in Xiangya Hospital, Central South University, 12 
cases of bladder cancer, 10 cases of prostate cancer, both by 
laboratory confirmed.
2.2. Main reagent
   MTT was from the Sigma company; Fetal bovine serum, 
was from Shanghai Yubo biological technology co., LTD..
ZTC1+1 natural clarifying agent was from Tianjin vibration 
Tiancheng technology co., LTD.. RPMI1640 media, IMDM 
medium, trypsin were from the United States GIBCO 
company; SDS was from Biotec company, USA. Thin layer 
silica gel plates were from Qingdao Marine chemical co., 
LTD. 
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2.3. Cell culture
  Bladder cancer EJ cell line and prostate PC-3M cell 
line were cultured respectively with RPMI1640 nutrient 
solution containing 12% fetal bovine serum and IMDM 
nutrient solution, at 37 曟, 5% CO2 incubator with saturated 
humidity,  change of nutrient solution every other day, until 
the cells began to grow in single layer, transfer of culture 
after digestion with 0.25% pancreatic enzyme solution. For 
log phase, two kinds of cells were collected and adjusted 
concentration to 1暳10
5 /mL for future uses.
2.4. In vitro  tumor inhibition test
   Take the log phase of EJ bladder cancer cells and prostate 
PC-3M cells,  for unicellular suspension of 1暳10
5/mL. 
The tumor cell line suspension was inoculated in 96 hole 
culture plate, with 0.1 mL in each hole, 10 毺L of different 
concentrations of Dau working liquid was added to each 
column respectively, with 6 complex holes. At the same time, 
10 毺L of PBS solution was added to the negative control, 
with 6 complex holes. And then the liquid was incubated in at 
37 曟, in saturated humidity, 5% CO2 incubator for 24 h, 48 h, 72 
h, 10 毺L of 4 mg/mL MTT was added 4 h before the end of 
incubation,  moved away the supernant after centrifugation, 
100 毺L of 15% dimethyl sulfoxide was added to each hole, 
for staying overnight. Cell proliferation rate was measured 
repeatedly for 3 times by enzyme league instrument at the 
570 nm wavelength (reference wavelength of 630 nm)[8-10], the 
inhibition rate (CI)=(OD value of control group-OD value of 
treatment group)/OD value of control group暳100% (Table 1).
Table 1
Drug concentration of in vitro inhibitory test  (毺g/mL).
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2.5 Drug sensitive test
   Standard suppression ratio CI曒50% is sensitive, 30%曑CI<50% 
is moderate sensitive, CI<30% is regarded as not having 
sensitive. Negative value indicates that drug stimulates cell 
growth.
2.6. Data processing and mathematical modeling 
   All test data are presented by mean±SD. The t test was 
applied to compare difference between groups. SPSS13.0 
software was used to analyze single factor variance. IC50 
was analyzed by using Microplate Manager TM4.0 data 
processing software (US BIO-RAD). All test results were 
repeatly analyzed for 3 times, by using improved Karber 
formula to calculation IC50. The processed data was used 
for mathematical modeling by Matlab 7.0 software, in the 
inhibition test, drug concentration was set as X (independent 
variables), proliferation inhibition rate was set as Y axis 
(dependent variable), according to the experimental data, 
regress function was used to get regression curve.
3. Results
3.1.  Effect of Dau to bladder cancer EJ cells
   Concentration above 8 毺g/mL of Dau showed good 
inhibition effect on EJ cells, with drug concentration rising, 
inhibition rate was rising, drug concentration and cell 
absorbance value was negatively correlated, but it had no 
obvious time dependence relationship, with the extension 
of time, the inhibition rate presented a rising trend (Figure 
1 and Table 2). Along with the drug concentration increases, 
poison effect is more obvious and have greater effect on 
killing tumor cells. However, this kind of cell poison effect 
only positively correlated with drug concentration, rather 
than with time length (Figure 2).
Table 2
Inhibition rate of EJ cell proliferation.
Drug (毺g/mL)                              Inhibition rate 
             24h        48h              72h
-              0.0         0.0                    0.0
64             83.5*       91.6*                  92.4*
32             73.4*       88.2*     89.8*
16             63.6*       75.8*                  83.6*
  8             57.6*       56.4*                    58.1*
  4             45.6*       21.8*            37.6*
  2             25.4*       12.8            24.6
  1             15.6         2.6                   14.1
0.5               1.5         1.8                     6.5
*: comparing with control group; -: P<0.05.
Figure 1. EJ cell absorbance under different drug concentration. 
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3.2. Effect of Dau to PC-3M cell and primary cells of urinary 
tract tumor
   Comparing with the negative control, concentration above 
8 毺g/mL of Dau above strong inhibition to PC-3M cell line, and 
present a good quantity activity relationship, IC50 of 24 h, 48 h and 
72 h were 31.2 毺g/mL, 7.2 毺g/mL and 6.7 毺g/mL. In 22 cases of 
primary culture of carcinoma tissue cell, 1 case did not take part in 
drug evaluation due to individual reason, the rest 21 patients with tumor 
cells presented different degree of sensitive to Dau, half inhibition 
concentration of 8 cases are between 8 to 16 毺g/mL, of 4 cases 
between 16 and 32 毺g/mL, of 4 cases between 32 to 64 毺g/mL and 
5 cases with half inhibition concentration more than 64 毺g/mL, 
the sensitive degree are lower than the tumor cell line (Figure 3 
and Figure 4).
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Figure 2. EJ cell proliferation inhibition effect under different concentrations of Dau. 
a: inhibition rate of 24 h after drug giving; b: inhibition rate of 48 h after drug giving; c: inhibition 
rate of 72 h after drug giving.
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Figure 4. PC-3M cell proliferation inhibition effect under different concentrations of Dau. 
a: inhibition rate of 24 h after drug giving; b: inhibition rate of 48 h after drug giving; c: inhibition 
rate of 72 h after drug giving.
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Figure 3. PC-3Mcell absorbance under different drug concentration. 
4. Discussion
   Many researches have confirmed that Dau had a stronger 
inhibitory proliferation effect on tumor cells[11-15]. Chen et 
al had confirmed that Dau showed strong cell toxicity on B 
cell lymphoma daudi cell, can restrain the growth of daudi 
cell proliferation[16]. Researchers used MTT experiments 
of different concentrations of Dau for prostate cancer PC-
3M cell line and bladder cancer cell lines BT5637, Dau had 
an inhibition effect with concentration dependency[17]. the 
researchers also find that Ds modulate myocardial’s active 
transport process of Na+ K+ Ca2+ with nonspecific inhibition, 
Dau can inhibit platelet aggregation and thrombosis[18], 
and protect nerve of short focal cerebral ischemia rats by 
mitochondrial pathway[19], can promote apoptosis of colon 
cancer through the NF-kB signal transduction channel, and 
have a variety of inhibition of proliferation and apoptosis 
induction effect against tumor certain cells[20-22]. Dau 
have a significant value-added inhibition to different 
main tumor in urinary system, and the lowest sensitive 
drug concentration are between 3.81 and 5.15 毺g/mL, the 
inhibition rate increased with increasing concentration time, 
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showed that Dau have a broad spectrum of anti-tumor effect, 
the mechanism is Dau and Ds conbine, inducing morphology 
change of cell apoptosis, volume shrinks, cytoplasmic 
enriches, followed by karyopyknosis and karyorrhexis. Dau 
and Ds have significant inhibition effect against proliferation 
of K562 (human erythroleukemia cell line), BGC823 (human 
gastric cancer cell line) and TE13 tumor cell. also has 
inhibition effect on neuroepithelium in primary culture.
   This study found that whether cell function is normal has 
a direct relationship with cancerous tissues[24]. At present, 
there are not many the researches about Dau application on 
resistance to urinary tract tumor cell, there are only some 
reports about the reverse multi-drug resistance. We have 
preliminarily studied the Dau’s cytotoxic effects against 
bladder tumor cell line and prostate cancer EJ and PC-3M 
tumor cell line, but the antitumor mechanism of Dauremains 
to be further studied. In addition, antitumor function of 
other monomer should still be further stydied, such as 
proliferation inhibition against Hela cell by polysaccharides 
from Dau, provide new drugs and approaches for clinical 
treatment of tumor diseases.
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